Chiome Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.2%.

Top 18 shareholders own 17.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.53%	SBI Holdings Inc., Asset Management Arm	1,428,550	JP¥170.0m	0%	0.07%
2.19%	Rakuten Investment Management, Inc.	1,234,000	JP¥146.8m	0%	0.07%
1.77%	Kenji Watanabe	1,000,000	JP¥119.0m	0%	no data
1.77%	Ueda Yagi Tanshi Co. Ltd., Asset Management Arm	998,800	JP¥118.9m	0%	0.14%
1.71%	Kunihiro Ohta	962,700	JP¥114.6m	0%	no data
1.67%	Growth Capital, Inc.	940,000	JP¥111.9m	6.82%	no data
1.06%	Koji Yoshimura	600,000	JP¥71.4m	0%	no data
0.89%	Matsui Securities Co. Ltd., Asset Management Arm	501,000	JP¥59.6m	0%	0.28%
0.88%	Tetsuo Iisaku	497,000	JP¥59.1m	0%	no data
0.81%	Shigekazu Hirata	455,000	JP¥54.1m	0%	no data
0.71%	Fukutaro Yamato	400,000	JP¥47.6m	0%	no data
0.62%	Sumitomo Mitsui Financial Group Inc., Asset Management Arm	346,600	JP¥41.2m	0%	no data
0.56%	au Kabucom Securities Co., Ltd., Asset Management Arm	313,551	JP¥37.3m	0%	0.15%
0.44%	Shigeru Kobayashi	246,200	JP¥29.3m	15.3%	no data
0.077%	Arihiko Bijohira	43,500	JP¥5.2m	99.5%	no data
0.041%	Teruyo Taoka	23,000	JP¥2.7m	130%	no data
0.023%	Akiyuki Furuya	13,000	JP¥1.5m	30%	no data
0.023%	Masamichi Koike	13,000	JP¥1.5m	0%	no data